iRhythm Technologies (IRTC) Competitors $73.74 -1.73 (-2.29%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IRTC vs. TNDM, NVCR, HAE, NVRO, TFX, PEN, GKOS, BLCO, INSP, and PRCTShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Tandem Diabetes Care (TNDM), NovoCure (NVCR), Haemonetics (HAE), Nevro (NVRO), Teleflex (TFX), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical" sector. iRhythm Technologies vs. Tandem Diabetes Care NovoCure Haemonetics Nevro Teleflex Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics iRhythm Technologies (NASDAQ:IRTC) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Is IRTC or TNDM more profitable? Tandem Diabetes Care has a net margin of -14.84% compared to iRhythm Technologies' net margin of -26.90%. Tandem Diabetes Care's return on equity of -44.19% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-26.90% -120.86% -17.96% Tandem Diabetes Care -14.84%-44.19%-11.99% Does the MarketBeat Community prefer IRTC or TNDM? Tandem Diabetes Care received 179 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.17% of users gave iRhythm Technologies an outperform vote while only 61.20% of users gave Tandem Diabetes Care an outperform vote. CompanyUnderperformOutperformiRhythm TechnologiesOutperform Votes40366.17% Underperform Votes20633.83% Tandem Diabetes CareOutperform Votes58261.20% Underperform Votes36938.80% Does the media prefer IRTC or TNDM? In the previous week, Tandem Diabetes Care had 4 more articles in the media than iRhythm Technologies. MarketBeat recorded 10 mentions for Tandem Diabetes Care and 6 mentions for iRhythm Technologies. Tandem Diabetes Care's average media sentiment score of 1.34 beat iRhythm Technologies' score of 0.88 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tandem Diabetes Care 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, IRTC or TNDM? iRhythm Technologies has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$492.68M4.68-$123.41M-$4.86-15.17Tandem Diabetes Care$747.72M2.65-$222.61M-$1.93-15.62 Do analysts recommend IRTC or TNDM? iRhythm Technologies currently has a consensus target price of $108.50, indicating a potential upside of 47.14%. Tandem Diabetes Care has a consensus target price of $54.25, indicating a potential upside of 79.93%. Given Tandem Diabetes Care's higher probable upside, analysts plainly believe Tandem Diabetes Care is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90Tandem Diabetes Care 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78 Which has more risk and volatility, IRTC or TNDM? iRhythm Technologies has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. SummaryTandem Diabetes Care beats iRhythm Technologies on 11 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.36B$4.46B$5.05B$8.87BDividend YieldN/A36.76%4.97%4.06%P/E Ratio-15.1714.8997.3414.18Price / Sales4.6847.261,218.4289.42Price / CashN/A52.2233.5132.79Price / Book32.205.475.805.12Net Income-$123.41M$13.76M$119.07M$225.99M7 Day Performance-11.63%-1.08%-1.83%-1.32%1 Month Performance18.74%0.58%-3.64%0.60%1 Year Performance-11.42%50.91%31.62%26.23% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies3.2268 of 5 stars$73.74-2.3%$108.50+47.1%-11.8%$2.31B$492.68M-15.172,000TNDMTandem Diabetes Care4.7486 of 5 stars$30.15+8.2%$54.25+79.9%+63.7%$1.98B$747.72M-15.622,400Positive NewsNVCRNovoCure3.7435 of 5 stars$17.10+1.4%$26.17+53.0%+38.3%$1.85B$509.34M-12.041,453HAEHaemonetics4.925 of 5 stars$84.92+0.1%$107.88+27.0%+2.4%$4.26B$1.31B35.243,657NVRONevro2.8885 of 5 stars$4.23-0.2%$9.10+115.1%-74.5%$158.50M$425.17M-2.241,215Analyst UpgradeGap DownTFXTeleflex4.8737 of 5 stars$189.00+0.8%$259.25+37.2%-12.7%$8.78B$2.97B37.2714,500Analyst DowngradePENPenumbra4.3239 of 5 stars$238.30-0.4%$227.92-4.4%+1.6%$9.15B$1.16B278.144,200Analyst ForecastInsider TradeGKOSGlaukos3.8428 of 5 stars$141.44-1.9%$134.55-4.9%+121.3%$7.80B$360.35M-46.83780Positive NewsBLCOBausch + Lomb2.3996 of 5 stars$19.38-0.9%$20.91+7.9%+23.2%$6.83B$4.15B0.0013,300INSPInspire Medical Systems4.9104 of 5 stars$186.80+1.1%$233.58+25.0%+29.2%$5.60B$624.80M172.781,011Analyst UpgradePositive NewsGap UpPRCTPROCEPT BioRobotics1.5867 of 5 stars$92.70-0.9%$89.50-3.5%+180.7%$4.84B$136.19M0.00626 Related Companies and Tools Related Companies Tandem Diabetes Care Alternatives NovoCure Alternatives Haemonetics Alternatives Nevro Alternatives Teleflex Alternatives Penumbra Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRTC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
